Evidence map›Paper›PMID 22081111›Full record

ArticleThe EMBO journal2012

Synthetic biology approach to reconstituting the ubiquitylation cascade in bacteria.

Tal Keren-Kaplan, Ilan Attali, Khatereh Motamedchaboki, Brian A Davis, Neta Tanner, Yael Reshef, Einat Laudon, Mikhail Kolot, Olga Levin-Kravets, Oded Kleifeld and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. CRL4Life science alliance · 2024
    Article
  7. Article
  8. Article
  9. Targeting TRIM Proteins: A Quest towards Drugging an Emerging Protein Class.Chembiochem : a European journal of chemical biology · 2021
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 3 countries.

Tal Keren-KaplanDepartment of Biochemistry and Molecular Biology, The Institute for Structural Biology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel.
Ilan Attali
Khatereh Motamedchaboki
Brian A Davis
Neta Tanner
Yael Reshef
Einat Laudon
Mikhail Kolot
Olga Levin-Kravets
Oded Kleifeld
Michael Glickman
Bruce F Horazdovsky
Dieter A Wolf
Gali Prag
Tel Aviv University · ILMayo Clinic in Arizona · USSanford Burnham Prebys Medical Discovery Institute · USMonash University · AUTechnion – Israel Institute of Technology · IL

Funding

Global Approaches to Protein UbiquitylationR01GM059780 · NIGMS · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI WOLF, DIETER A · 1999 to 2010
$3.8M
Comprehensive proteomic profiling of the ubiquitin pathway in cancerRC2CA148414 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI WOLF, DIETER A · 2009 to 2010
$1.8M
NCI NIH HHS RC2 CA148414NIGMS NIH HHS GM59780NIGMS NIH HHS R01 GM059780
6 · The paper itself

Abstract

Covalent modification of proteins with ubiquitin (Ub) is widely implicated in the control of protein function and fate. Over 100 deubiquitylating enzymes rapidly reverse this modification, posing challenges to the biochemical and biophysical characterization of ubiquitylated proteins. We circumvented this limitation with a synthetic biology approach of reconstructing the entire eukaryotic Ub cascade in bacteria. Co-expression of affinity-tagged substrates and Ub with E1, E2 and E3 enzymes allows efficient purification of ubiquitylated proteins in milligram quantity. Contrary to in-vitro assays that lead to spurious modification of several lysine residues of Rpn10 (regulatory proteasomal non-ATPase subunit), the reconstituted system faithfully recapitulates its monoubiquitylation on lysine 84 that is observed in vivo. Mass spectrometry revealed the ubiquitylation sites on the Mind bomb E3 ligase and the Ub receptors Rpn10 and Vps9. Förster resonance energy transfer (FRET) analyses of ubiquitylated Vps9 purified from bacteria revealed that although ubiquitylation occurs on the Vps9-GEF domain, it does not affect the guanine nucleotide exchanging factor (GEF) activity in vitro. Finally, we demonstrated that ubiquitylated Vps9 assumes a closed structure, which blocks additional Ub binding. Characterization of several ubiquitylated proteins demonstrated the integrity, specificity and fidelity of the system, and revealed new biological findings.

Indexed as

Adaptor Proteins, Vesicular TransportAffinity LabelsCloning, MolecularEscherichia coliFluorescence Resonance Energy TransferGenetic VectorsGuanine Nucleotide Exchange FactorsGuanosine DiphosphatePlant ProteinsProteasome Endopeptidase ComplexProtein Processing, Post-TranslationalRecombinant Fusion ProteinsSaccharomyces cerevisiae ProteinsSubstrate SpecificitySynthetic BiologyUbiquitinAdaptor Proteins, Vesicular TransportAffinity LabelsepsinGuanine Nucleotide Exchange FactorsGuanosine DiphosphatePlant ProteinsProteasome Endopeptidase ComplexRecombinant Fusion ProteinsRPN10 protein, S cerevisiaeSaccharomyces cerevisiae ProteinsUbc4 protein, S cerevisiaeUBC5 protein, S cerevisiaeUbiquitinUbiquitin-Activating EnzymesUbiquitin-Conjugating EnzymesUbiquitin-Protein Ligase ComplexesUbiquitin-Protein LigasesVesicular Transport ProteinsVPS9 protein, S cerevisiaeZebrafish Proteins

Identifiers

PMID22081111
PMCPMC3261559
OpenAlexW1917462063

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.